Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11409)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2017 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang J, Guo XJ, Ding YM, Jiang JX. miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer. World J Gastroenterol 2017; 23(9): 1594-1601 [PMID: 28321160 DOI: 10.3748/wjg.v23.i9.1594] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i9/1594.htm |
| Number | Citing Articles |
| 1 |
Eerdunduleng Eerdunduleng. circ-LDLRAD3 regulates cell proliferation, migration and invasion of pancreatic cancer by miR-876-3p/STAT3. Clinical Surgery Research Communications 2019; 1(1): 08 doi: 10.31491/CSRC.2019.03.027
|
| 2 |
Zhengjiang Qian, Yanjiao Li, Haiyang Yang, Jidong Chen, Xiang Li, Deming Gou. PDGFBB promotes proliferation and migration via regulating miR-1181/STAT3 axis in human pulmonary arterial smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 2018; 315(6): L965 doi: 10.1152/ajplung.00224.2018
|
| 3 |
Evita Maria Lindholm, Miriam Ragle Aure, Mads Haugland Haugen, Kristine Kleivi Sahlberg, Vessela N. Kristensen, Daniel Nebdal, Anne‐Lise Børresen‐Dale, Ole Christian Lingjærde, Olav Engebraaten. miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer. Molecular Oncology 2019; 13(10): 2278 doi: 10.1002/1878-0261.12561
|
| 4 |
Duo Zhi, Xin Zhao, Mei Dong, Caichuan Yan. miR‑493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression. Oncology Letters 2017; doi: 10.3892/ol.2017.7178
|
| 5 |
Hui Wang, Zhengdong Zhang, Zhe Yan, Shihong Ma. CKS1B promotes cell proliferation and invasion by activating STAT3/PD‐L1 and phosphorylation of Akt signaling in papillary thyroid carcinoma. Journal of Clinical Laboratory Analysis 2021; 35(1) doi: 10.1002/jcla.23565
|
| 6 |
Gemma van Duijneveldt, Michael D.W. Griffin, Tracy L. Putoczki. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clinical Science 2020; 134(16): 2091 doi: 10.1042/CS20191211
|
| 7 |
Ayla Orang, Saira R. Ali, Janni Petersen, Ross A. McKinnon, Amanda L. Aloia, Michael Z. Michael. A functional screen with metformin identifies microRNAs that regulate metabolism in colorectal cancer cells. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06587-9
|
| 8 |
Zewen Song, Zhaomei Yu, Limin Chen, Zhijiao Zhou, Qiong Zou, Yang Liu. MicroRNA-1181 supports the growth of hepatocellular carcinoma by repressing AXIN1. Biomedicine & Pharmacotherapy 2019; 119: 109397 doi: 10.1016/j.biopha.2019.109397
|
| 9 |
Ziba Lotfi, Shiva Najjary, Fariba Lotfi, Mohammad Amini, Amir Baghbanzadeh, Darya Javad Rashid, Elmira Roshani Asl, Behzad Baradaran, Ahad Mokhtarzadeh. Crosstalk between miRNAs and signaling pathways involved in pancreatic cancer and pancreatic ductal adenocarcinoma. European Journal of Pharmacology 2021; 901: 174006 doi: 10.1016/j.ejphar.2021.174006
|
| 10 |
Bai-Shun Wan, Ming Cheng, Ling Zhang. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation <i>via</i> activation of AKT and is directly targeted by microRNA-494 in pancreatic cancer. World Journal of Gastroenterology 2019; 25(40): 6063-6076 doi: 10.3748/wjg.v25.i40.6063
|
| 11 |
Mengqi Liu, Lingping Fu, Hao Fu, Yu Chen, Mengxia Wu, Hanchun Liu. Pharmacological underlying mechanisms of the anticancer effect of licorice: Bioinformatics and experimental verification. Journal of Holistic Integrative Pharmacy 2024; 5(1): 45 doi: 10.1016/j.jhip.2024.04.006
|
| 12 |
Behrooz Johari, Mohammad Rahmati, Leila Nasehi, Yousef Mortazavi, Mohammad Hasan Faghfoori, Hamed Rezaeejam. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line. Cell Biology International 2020; 44(12): 2499 doi: 10.1002/cbin.11456
|
| 13 |
Feng Liu, Guodong Ma, Bo Wang, Xiang Wang, Chenjun Huang. Prognostic value of miR‑1181 in non‑small cell lung cancer and its regulatory effect on tumor progression. Experimental and Therapeutic Medicine 2021; 22(5) doi: 10.3892/etm.2021.10719
|
| 14 |
Hui Hu, Qin Zhang, Weiqun Chen, Tangwei Wu, Shuiyi Liu, Xiaoyi Li, Bo Luo, Tianzhu Zhang, Ge Yan, Hongda Lu, Zhongxin Lu. MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5. Carcinogenesis 2020; 41(4): 502 doi: 10.1093/carcin/bgz121
|
| 15 |
Lin Zhang, Junyao Li, Qi Wang, Guangping Meng, Xuejiao Lv, Hong Zhou, Wei Li, Jie Zhang. The relationship between microRNAs and the STAT3-related signaling pathway in cancer. Tumor Biology 2017; 39(7): 101042831771986 doi: 10.1177/1010428317719869
|
| 16 |
Milad Ashrafizadeh, Chakrabhavi D. Mohan, Shobith Rangappa, Ali Zarrabi, Kiavash Hushmandi, Alan Prem Kumar, Gautam Sethi, Kanchugarakoppal S. Rangappa. Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response. Medicinal Research Reviews 2023; 43(5): 1263 doi: 10.1002/med.21950
|
| 17 |
Mohadeseh Fathi, Soudeh Ghafouri-Fard, Atefe Abak, Mohammad Taheri. Emerging roles of miRNAs in the development of pancreatic cancer. Biomedicine & Pharmacotherapy 2021; 141: 111914 doi: 10.1016/j.biopha.2021.111914
|
| 18 |
Carson J Bryant, Mason A McCool, Gabriela T Rosado González, Laura Abriola, Yulia V Surovtseva, Susan J Baserga. Discovery of novel microRNA mimic repressors of ribosome biogenesis. Nucleic Acids Research 2024; 52(4): 1988 doi: 10.1093/nar/gkad1235
|
| 19 |
Lu-Lu Sun, Ming Cheng, Xiao-Dong Xu. MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis. World Journal of Gastroenterology 2019; 25(42): 6311-6321 doi: 10.3748/wjg.v25.i42.6311
|
| 20 |
Doudou Jing, Wei Wu, Xuanzuo Chen, Hongwei Xiao, Zhenhao Zhang, Fengxia Chen, Zhicai Zhang, Jianxiang Liu, Zengwu Shao, Feifei Pu. Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1. Pharmacological Research 2022; 182: 106287 doi: 10.1016/j.phrs.2022.106287
|
| 21 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Konstantinos Papanikolopoulos, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Michalis V. Karamouzis. The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. Genes 2022; 13(10): 1868 doi: 10.3390/genes13101868
|
| 22 |
Eleni Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, Nikolaos Papadopoulos, Sotirios P. Fortis, Vassilis L. Tzounakas, Alkmini T. Anastasiadi, Panagiotis Sarantis, Sofia Vasileiadi, Ariadne Tsagarakis, Georgios Aloizos, Spilios Manolakopoulos, Melanie Deutsch. A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment. International Journal of Molecular Sciences 2024; 25(6): 3406 doi: 10.3390/ijms25063406
|
| 23 |
Karen Uray, Evelin Major, Beata Lontay. MicroRNA Regulatory Pathways in the Control of the Actin–Myosin Cytoskeleton. Cells 2020; 9(7): 1649 doi: 10.3390/cells9071649
|
| 24 |
Mohammad Rahmati, Behrooz Johari, Mehdi Kadivar, Elham Rismani, Yousef Mortazavi. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy. Journal of Cellular Physiology 2020; 235(6): 5429 doi: 10.1002/jcp.29431
|
| 25 |
Yujuan Chen, Ya Liu, Yu Wang, Wen Li, Xiaolu Wang, Xuejuan Liu, Yao Chen, Chibin Ouyang, Jing Wang. Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer. Medicine 2017; 96(45): e8488 doi: 10.1097/MD.0000000000008488
|
| 26 |
Tinggang Mou, Fei Xie, Pingyong Zhong, Hao Hua, Liang Lai, Qin Yang, Jie Wang. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8. Biomedicine & Pharmacotherapy 2019; 111: 891 doi: 10.1016/j.biopha.2018.12.121
|
| 27 |
Yagmur Minareci, Naziye Ak, Hamdullah Sozen, Ozgur A. Tosun, Canan Kucukgergin, Fatih Aydin, İlknur Bingul, M. Yavuz Salihoglu, Samet Topuz. The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09464-y
|
| 28 |
Shi‐Min Chang, Wei‐Wei Hu. Long non‐coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA‐125b/STAT3 axis. Journal of Cellular Physiology 2018; 233(4): 3384 doi: 10.1002/jcp.26185
|
| 29 |
Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, Habbanakuppe D. Preetham, S. Chandra Nayaka, Vijai K. Gupta, Salundi Basappa, Gautam Sethi, Kanchugarakoppal S. Rangappa. Targeting STAT3 signaling pathway in cancer by agents derived from Mother Nature. Seminars in Cancer Biology 2022; 80: 157 doi: 10.1016/j.semcancer.2020.03.016
|